Sodium cromoglicate ocular
- Drugs List
- Therapeutic Indications
- Dosage
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Sodium cromoglicate eye drops preservative containing.
Drugs List
Therapeutic Indications
Uses
Seasonal and perennial allergic conjunctivitis
Dosage
Adults
Instil one or two drop(s) into each affected eye up to four times daily, or as indicated by the physician.
Children
Instil one or two drop(s) into each affected eye up to four times daily, or as indicated by the physician.
Not all brands are licensed for children under 6 years.
Contraindications
None known
Precautions and Warnings
Children under 6 years
Soft contact lenses
Pregnancy
Advise patient blurred vision may affect ability to drive/operate machinery
Not all available brands are licensed for all indications
Not all available brands are licensed for use in children under 6 years
Contains benzalkonium chloride
Discard any remaining solution 28 days after opening
In combined therapy, administer eye products at least five minutes apart
To reduce systemic absorption compress lacrimal sac during administration
Advise patient to avoid touching the eye/other surfaces with container tip
Advise patient to seek medical advice if treatment is ineffective
If soft contact lenses worn,insert them 15 minutes after using eye drops
Pregnancy and Lactation
Pregnancy
Use sodium cromoglicate eye drops with caution in pregnancy.
The manufacturer notes that this medication should only be considered if the expected benefit to the mother is greater than any risk to the foetus.
Cumulative experience suggests that sodium cromoglicate has no adverse effects on foetal development.
Lactation
Sodium cromoglicate eye drops are considered safe to use in breastfeeding.
The manufacturer notes that it is unknown if sodium cromoglicate is excreted into human breast milk but on the basis of its physio-chemical properties, this is considered unlikely.
There is little information to suggest that the use of sodium cromoglicate has any undesirable effects on the baby.
Side Effects
Blurred vision (transient)
Burning sensation (local)
Irritation (localised)
Stinging (transient)
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Further Information
Last Full Review Date: May 2019
Reference Sources
Summary of Product Characteristics: Allergy Relief 2% w/v eye drops, solution; Optrex Allergy 2% w/v Eye Drops, Solution; Opticrom Allergy 2% Eye Drops, Solution. Aspire Pharma Limited. Revised March 2018.
Summary of Product Characteristics: Opticrom Aqueous 2% w/v Eye Drops, solution. Aspire Pharm Limited. Revised November 2018.
Summary of Product Characteristics: Polenase Hayfever Relief 2% w/v Eye Drops, solution. Aspire Pharm Limited. Revised August 2018.
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.